Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Morrison & Foerster advised Sequlite Genomics, a company that focuses on Next-Generation Sequencing (NGS), in connection with its sale to Fapon Biotech, a biotechnology services company based in China that develops, manufactures, and sells products that provide global diagnostic companies with high-performance in vitro diagnostic reagent raw materials, as well as reagent solutions and innovative open instrument platforms. Sequlite specializes in the research and development of high-throughput NGS instruments and reagents.



MoFo Advises Sequlite on Sale to Fapon Biotech

About Morrison Forester

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Morrison & Foerster advised Sequlite Genomics, a company that focuses on developing Next-Generation Sequencing (NGS) technology, in connection with its sale to Fapon Biotech, a biotechnology services company based in China that develops, manufactures, and sells products that provide global diagnostic companies with high-performance in vitro diagnostic reagent raw materials, as well as reagent solutions and innovative open instrument platforms. Sequlite specializes in the research and development of NGS instruments and reagents.The MoFo team advising Sequlite was led by San Diego corporate partner Jim Krenn, together with San Diego corporate associates Andrew Dixon, Pat Boyle, Carey Hughes and Brennen Brodersen. The wider team included San Francisco tax partner Maureen Linch and tax associates Lauren Keller and Jessica Stern, San Francisco executive compensation partner Amanda Hines Gold and associate John O’Neill, Palo Alto labor of counsel Lloyd Aubry, Boston TTG partner Matt Karlyn and associate Mai Zymaris, Hong Kong TTG partner Chuan Sun, Hong Kong corporate senior of counsel Stephen Birkett, Beijing corporate associate Richard Ji, Shanghai corporate associate Tian Zhou, Washington D.C. partner Aki Bayz, and many others.